1
Rilonacept for Treatment of Autoimmune Neurosensory Hearing Loss
Condition(s):Autoimmune Neurosensory Hearing Loss (ANSHL)Last Updated:September 13, 2017Unknown status
Rilonacept: 28 Clinical Trials, Page 1 of 3
Hide Studies Not Open or Pending
2
Cold Contact Urticaria Treatment With Rilonacept
Condition(s):Cold Contact UrticariaLast Updated:July 17, 2018Completed
3
RHAPSODY Phase 3 Study to Assess the Efficacy and Safety of Rilonacept Treatment in Subjects With Recurrent Pericarditis
Condition(s):Recurrent PericarditisLast Updated:March 9, 2021Active, not recruiting
4
Rilonacept (Arcalyst ®) in the Treatment of Subacromial Bursitis
Condition(s):Subacromial BursitisLast Updated:August 4, 2014Completed
5
Rilonacept for Deficiency of the Interleukin-1 Receptor Antagonist (DIRA)
Condition(s):DIRALast Updated:October 16, 2017Completed
6
Rilonacept in Diabetes Mellitus Type 1: Safety Study
Condition(s):Type 1 Diabetes MellitusLast Updated:February 24, 2014Completed
7
Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)
Condition(s):Renal Insufficiency, ChronicLast Updated:September 12, 2016Completed
8
IL1-TRAP, Rilonacept, in Systemic Sclerosis
Condition(s):Scleroderma; Systemic Sclerosis; Diffuse Scleroderma; Diffuse Systemic SclerosisLast Updated:May 1, 2018Completed
9
Rilonacept for Treatment of Familial Mediterranean Fever (FMF)
Condition(s):Familial Mediterranean FeverLast Updated:February 11, 2013Completed
10
Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)
Condition(s):Muckle-Wells Syndrome; Schnitzler SyndromeLast Updated:May 31, 2012Completed